Variant report
Variant | esv3327445 |
---|---|
Chromosome Location | chr5:5215102-5217100 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531198644 | chr5:5215105-5215106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs142695078 | chr5:5215129-5215130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116305657 | chr5:5215159-5215160 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527503246 | chr5:5215162-5215163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552603115 | chr5:5215181-5215182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs571077712 | chr5:5215222-5215223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558404285 | chr5:5215228-5215229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150601515 | chr5:5215248-5215249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78200136 | chr5:5215262-5215263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs80240394 | chr5:5215263-5215264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4365819 | chr5:5215265-5215266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185449299 | chr5:5215279-5215280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115534569 | chr5:5215284-5215285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574676782 | chr5:5215336-5215337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs369885095 | chr5:5215374-5215375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188648077 | chr5:5215385-5215386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372647840 | chr5:5215545-5215546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181479920 | chr5:5215551-5215552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535581814 | chr5:5215584-5215585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557033760 | chr5:5215585-5215586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538528285 | chr5:5215609-5215610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575277057 | chr5:5215683-5215684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559029345 | chr5:5215705-5215706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566003465 | chr5:5215720-5215721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4702246 | chr5:5215753-5215754 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs555228370 | chr5:5215787-5215788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs376288127 | chr5:5215793-5215794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536965853 | chr5:5215810-5215811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201546546 | chr5:5215820-5215821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201821638 | chr5:5215822-5215823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs57628837 | chr5:5215826-5215827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs137932008 | chr5:5215830-5215831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs56041596 | chr5:5215831-5215832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs397703864 | chr5:5215841-5215842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570739760 | chr5:5215859-5215860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544167802 | chr5:5215881-5215882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557646539 | chr5:5215888-5215889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200219964 | chr5:5215892-5215893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs373236533 | chr5:5215903-5215904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs370414672 | chr5:5215906-5215907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376079866 | chr5:5215918-5215919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs56115820 | chr5:5215922-5215923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs55667515 | chr5:5215939-5215940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545534423 | chr5:5215949-5215950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374604690 | chr5:5215954-5215955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs367721030 | chr5:5215955-5215956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs13160614 | chr5:5215970-5215971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374060998 | chr5:5215984-5215985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs13181302 | chr5:5215985-5215986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs200212021 | chr5:5215987-5215988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Schizophrenia | 23813976 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:5185200-5262800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr5:5193800-5219000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr5:5199000-5240000 | Weak transcription | H9 Cell Line | embryonic stem cell |
4 | chr5:5199800-5228200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr5:5200200-5252800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
6 | chr5:5201400-5223000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
7 | chr5:5201400-5226000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
8 | chr5:5202600-5240200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
9 | chr5:5205400-5222400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr5:5209600-5221000 | Weak transcription | Ovary | ovary |
11 | chr5:5209600-5222000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr5:5210000-5220800 | Weak transcription | NH-A | brain |
13 | chr5:5210200-5217800 | Weak transcription | Fetal Kidney | kidney |
14 | chr5:5210200-5218400 | Weak transcription | Psoas Muscle | Psoas |
15 | chr5:5214600-5215200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
16 | chr5:5215000-5215400 | Enhancers | Brain Substantia Nigra | brain |
17 | chr5:5215200-5215400 | Enhancers | Brain Cingulate Gyrus | brain |